NEUROLOGICAL INJURY and RENAL REPLACEMENT THERAPY Lina C. Laxamana, FPCP, FPNA Neurocritical Care Unit October 8, 2010 NKTI Post Graduate Course
Mar 26, 2015
NEUROLOGICAL INJURY and RENAL REPLACEMENT
THERAPY
Lina C. Laxamana, FPCP, FPNANeurocritical Care Unit
October 8, 2010NKTI Post Graduate Course
Renal Replacement Therapy• Indications:– Severe hyperkalemia– Fluid overload– Refractory acidosis– Uremic symptoms:• Serositis• Encephalopathy• Bleeding
• Objectives:– Remove excess volume– Remove solutes
Renal Replacement Therapy
Intensity of RRT and outcome in critically ill patients with ARF
CASE
• M.B., 56/M, married, from Isabela • Admitted due to sudden onset of R sided
weakness and aphasia • ~11 hours PTA– Sudden onset of R sided weakness, with aphasia– Brought to a local hospital– Cranial CT requested
Imaging ( 2 ½ hours)
Imaging (2 ½ hours)
Imaging (2 ½ hours)
Imaging (2 ½ hours)
Imaging (2 ½ hours)
• Intracerebral hematoma with an estimated volume of 30cc in the L capsuloganglionic region.
• With perilesional edema, mass effect and midline shift
• No IVE, HCP
Case • PMHx–With HPN, DM II, CAD–With ESRD requiring HD every 5th day
through a L brachial AV fistula–Maintained on Plavix 75mg/tab, ½ tab daily–Denies allergies
• PSHx–unremarkable
Pertinent examination • E4V2M6• Cranial nerves–Pupils 2mm EBRTL–R central facial palsy–Good gag– Tongue deviated to the R
• Motors UE R 0/5 L 5/5 LE R 0/5 L 5/5
Case • Pertinent labs–CBC 13.3/44.1/11.1/N92/249–BT 4’ CT 5’–PTT 35.1s PT 85% INR 1.06–Na 127 K 5.89 –BUN 34 Crea 6.77
• Cranial CT repeated
Imaging (10 ½ hours)
Imaging (10 ½ hours)
Imaging (10 ½ hours)
• L capsuloganglionic acute intraparenchymal hematoma (42cc)
• Surrounding edema
• Compression of the ipsilateral ventricle and slight midline shift to the right
Case • Admitted to NCCU–Started on Mannitol 60gms q4–Neuro status quo: E4v2m6•Pupils 2mm EBRTL• Slight headache
–Started on HD
Day 2 • Day 3 post ictus (830am)– E2v1m6, drowsier–BP 150/90 HR 90 O2sat 95% T 37.8C –Pupils 1mm, equal–Na 126 (124) K 5.89 (6.26)– Stat CT scan requested• NPO• Additional Mannitol 30gms bolus given
Imaging (day 2)
Imaging (day 2)
Imaging (day 2)
Imaging (day 2)
• Interval evolution to beginning subacute stage
• Without increase in volume
• Interval progression of perilesional edema
• Midline shift to the right has not significantly changed
Case • Day 3 post ictus (915am)
–Prepared for surgery–Repeat PT 138% INR 0.88 PTT 31.1s –Na and K correction–Mannitol continued at 60gms q4–Hemodialysis–Clearances requested
Case • Day 3 post ictus (1110am)– Elective intubation done (Anes)
• Day 3 post ictus (515pm)– E2vtm5, more difficult to arouse–BP 166/100 HR 90 O2sat 100%–Pupils 2-3mm EBRTL–Awaiting repeat labs post HD
Case • Day 3 post ictus (10pm)–K 4.35– Scheduled for surgery at 4am
• Day 4 post ictus (120am)– E2vtm5–BP 160/90 HR 88 O2sat 98%–Pupils 2-3mm EBRTL
Case • Day 4 post ictus (4am)–OR
• Plan– L frontal craniotomy, endoscopic
evacuation of hematoma with intraparenchymal ICP monitor probe insertion
Case • Goals for treatment–Address the increased intracranial pressure
from the hematoma– Evacuate the capsuloganglionic hemorrhage– Lessen the need for osmotic diuretics in an
ESRD patient
Surgery
Surgery
Surgery
Surgery
4th day post-op
Renal Replacement Therapy and the
Neurocritical Care Patient
Lang & Chestnut, Neurosurg Clin N Am 1994;5(4):573-605
Cerebral Blood Flow
Cerebral Blood Flow
Bhardwaj A. Cerebral blood flow. In Suarez JI, Critical Care Neurology and Neurosurgery, Humana Press, 2004 with permission
• MAP = 2 (diastolic) + systolic 3• CPP = MAP - ICP• CBF = Cerebral Perfusion Pressure Cerebral Vascular Resistance =P x x r4 / 8 x L x (Hagen-Poiseuille equation for movement of Newtonian fluids in large caliber vessels)• Autoregulation: MAP 60-150 mmHg
IHD and ICP
From: Davenport A. Hemod Internl 2008;12:307–312 with permission
MAP and CAPD
From: Davenport A. Hemod Internl 2008;12:307–312 with permission
Effect of renal replacement on ICP
From: Davenport A. Semin Dialysis, 2009;22:165–168 with permission
Serum osmolality following renal replacement
From: Davenport A. Semin Dialysis, 2009;22:165–168 with permission
Modifications to standard hemodialysis prescription that may potentially reduce risk of further cerebral
injury in patients with acute cererbal injury
From: Davenport A. Hemod Internl 2008;12:307–312 with permission
Conclusion
• CRRT may have beneficial effects in patients with RIH
• Further research may be warranted
Fletcher et al, J Trauma, Critical Care ,2010
Has CRRT caused ICP reduction?
• Unknown mechanism• Removal of cytokines and myocardial
depressants seen with ultrafiltration and membrane absorption
Fletcher et al, J Trauma, Critical Care ,2010
Statement
• CRRT is the preferred mode in ABI• Previous studies did not show decrease in ICP
but rather only stability• patient population• mode of CRRT used • membrane biocompatibility
Davenport; Nephrol Dial Transplant. 1990;5:192–198 Br Med J (Clin Res Ed). 1987;295:1028.
Osmotherapy
• If elevations in ICP are noted or cerebral edema:– Treatment of ICP should continue as usual–20% mannitol infusions–Hypertonic saline with the dialysate to keep
serum sodium 150-155 mEq/L
Renal Failure and Neurosurgery
• Emergency surgical evacuation• Correct coagulopathy:–Platelet transfusion–DDAVP–Correct INR
• RRT as indicated above
Conclusions• Renal failure is common in the ICU• Less common in patients with neurological
injury• All risk factors should be corrected• Continuous replacement therapies are
preferred • Close communication and team work with
nephrologists are key
THANK YOU